MyBlueDots

Tongue cancer organoids reveal secrets of chemotherapy resistance

MyBlueDots5 months ago01 mins

Oral cancer is an increasingly prevalent disease worldwide, with over 300,000 new cases diagnosed each year. Among oral cancers, tongue cancer (TC) is the most common type and often carries a poor prognosis.

Super-resolution microscopy shows how therapeutic antibodies work against cancer cells

MyBlueDots5 months ago01 mins

In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of therapy involves labeling the CD20 protein on the surface of the B cells with customized antibodies. This triggers a chain of immunological reactions and ultimately leads to the destruction of the cancer cells.

Celiac disease linked to chronic liver disease

MyBlueDots5 months ago01 mins

Patients with celiac disease face an increased risk of developing any chronic liver disease. This risk increase can persist for at least 25 years after celiac diagnosis. The findings, published in The Lancet Regional Health—Europe, underscore clinical vigilance for signs of liver disease in patients with celiac disease to prevent major adverse liver outcomes.

MyBlueDots

MAIA Biotechnology to Present at Biotech Showcase 2025

MyBlueDots5 months ago01 mins

CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology to Present at Biotech Showcase 2025

Telehealth abortion services surge as distance from clinics increases: Study

MyBlueDots5 months ago01 mins

The distance between a patient’s home and an abortion-services facility where they would seek care significantly influences how they receive birth-control medications, according to a study published Jan. 8 in the American Journal of Public Health.

Pandemic ‘exacerbated NHS struggle to meet demand’

MyBlueDots5 months ago01 mins

NHS Scotland must treat at least 20% more non-emergency hospital cases over the next three years to eliminate the backlog caused by the COVID-19 pandemic, according to new analysis involving the University of Strathclyde.

Air pollution emerges as a growing concern in risk factors linked to lung cancer deaths

MyBlueDots5 months ago01 mins

Even though lung and related cancer deaths decreased in the world’s 10 most populous countries from 1990 to 2019, these positive statistics do not address trends in mortality linked to tobacco use, air pollution and asbestos exposure. Those areas need ongoing policy measures and research to further reduce deaths, according to a new study from researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and collaborating organizations.

High blood pressure in pregnancy a risk factor for early heart disease

MyBlueDots5 months ago01 mins

A study has revealed a significant link between a common pregnancy complication and early heart disease in women. The study is published in the Journal of the American College of Cardiology.

MyBlueDots

Bayer Submits Supplemental New Drug Application to U.S. FDA Seeking New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40%

MyBlueDots5 months ago01 mins

WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer today announced the submission of a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for KERENDIA® (finerenone) for the treatment of patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of ≥40%. The submission is based on positive results from the Phase III FINEARTS-HF trial that showed finerenone achieved a statistically significant reduction of the composite of cardiovascular death and t

MyBlueDots

New Mountain Capital to Acquire Machinify and Combine with Leading Healthcare Intelligence and Payment Platform

MyBlueDots5 months ago01 mins

NEW YORK & DALLAS & PALO ALTO, Calif.–(BUSINESS WIRE)–New Mountain Capital, LLC (“New Mountain”), a leading growth-oriented investment firm with more than $55 billion in assets under management, today announced a definitive agreement to acquire Machinify, Inc. (“Machinify”), a leading provider of artificial intelligence (AI)-powered software transforming healthcare payments. Machinify will become a core part of the company recently formed through the merger of The Rawlings Group (“Rawlings”),

Useful _Links

‘Master control switch’ protein that heightens neurodegenerative disease offers new treatment target

New findings reveal how the heart is organized from the earliest stages of embryonic development

Study sheds light on enzyme’s role in driving lymphoma growth

Scholastic performance is a key concern for young cancer patients, study finds

When climate disasters hit, they often leave long-term health care access shortages, study finds

Food as friend, not foe—study maps cellular network that enables safe food consumption through oral tolerance

Tongue cancer organoids reveal secrets of chemotherapy resistance

Super-resolution microscopy shows how therapeutic antibodies work against cancer cells

Celiac disease linked to chronic liver disease

MAIA Biotechnology to Present at Biotech Showcase 2025

Telehealth abortion services surge as distance from clinics increases: Study

Pandemic ‘exacerbated NHS struggle to meet demand’

Air pollution emerges as a growing concern in risk factors linked to lung cancer deaths

High blood pressure in pregnancy a risk factor for early heart disease

Bayer Submits Supplemental New Drug Application to U.S. FDA Seeking New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40%

New Mountain Capital to Acquire Machinify and Combine with Leading Healthcare Intelligence and Payment Platform

World News

Useful Links

Health

Business

Entertainment

About Us